Arcturus Therapeutics Holdings Stock Analysis

Arcturus Stock Analysis Notes

About 90.0% of the company shares are held by institutions such as insurance companies. The book value of Arcturus Therapeutics was presently reported as 10.38. The company has Price/Earnings (P/E) ratio of 119.5. Arcturus Therapeutics recorded a loss per share of 1.12. The entity last dividend was issued on the 16th of November 2017. The firm had 1:7 split on the 16th of November 2017. Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company was founded in 2013 and is headquartered in San Diego, California. Arcturus Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 177 people. For more info on Arcturus Therapeutics Holdings please contact David Baker at 858 900 2660 or go to https://arcturusrx.com.

Arcturus Therapeutics Investment Alerts

Arcturus Therapeutics Upcoming and Recent Events

Arcturus Largest EPS Surprises

View All Earnings Estimates

Arcturus Stock Institutional Investors

Note, although Arcturus Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Arcturus Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 699.26 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arcturus Therapeutics's market, we take the total number of its shares issued and multiply it by Arcturus Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Arcturus Profitablity

The company has Profit Margin (PM) of (0.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.59) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.59.

Management Efficiency

Arcturus Therapeutics has return on total asset (ROA) of (0.1111) % which means that it has lost $0.1111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1083) %, meaning that it created substantial loss on money invested by shareholders. Arcturus Therapeutics' management efficiency ratios could be used to measure how well Arcturus Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.07 in 2024. Return On Capital Employed is likely to drop to -0.01 in 2024. At this time, Arcturus Therapeutics' Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 450.9 M in 2024, whereas Non Current Liabilities Total is likely to drop slightly above 38.2 M in 2024.

Technical Drivers

As of the 23rd of April, Arcturus Therapeutics shows the risk adjusted performance of (0.03), and Mean Deviation of 3.17. Arcturus Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down thirteen technical drivers for Arcturus Therapeutics Holdings, which can be compared to its peers. Please confirm Arcturus Therapeutics risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Arcturus Therapeutics is priced correctly, providing market reflects its regular price of 27.06 per share. Given that Arcturus Therapeutics has information ratio of (0.09), we suggest you to validate Arcturus Therapeutics Holdings's prevailing market performance to make sure the company can sustain itself at a future point.

Arcturus Therapeutics Price Movement Analysis

Arcturus Therapeutics Insider Trading Activities

Arcturus Therapeutics Predictive Daily Indicators

Arcturus Therapeutics Corporate Filings

Arcturus Therapeutics Forecast Models

Arcturus Therapeutics' time-series forecasting models are one of many Arcturus Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arcturus Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Arcturus Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Arcturus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Arcturus Therapeutics. By using and applying Arcturus Stock analysis, traders can create a robust methodology for identifying Arcturus entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Arcturus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Arcturus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Arcturus Therapeutics Holdings stock analysis indicators help investors evaluate how Arcturus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Arcturus Therapeutics shares will generate the highest return on investment. By understating and applying Arcturus Therapeutics stock analysis, traders can identify Arcturus Therapeutics position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcturus Therapeutics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Arcturus Therapeutics information on this page should be used as a complementary analysis to other Arcturus Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

When running Arcturus Therapeutics' price analysis, check to measure Arcturus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcturus Therapeutics is operating at the current time. Most of Arcturus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arcturus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcturus Therapeutics' price. Additionally, you may evaluate how the addition of Arcturus Therapeutics to your portfolios can decrease your overall portfolio volatility.

Is Arcturus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcturus Therapeutics. If investors know Arcturus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcturus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Arcturus Therapeutics is measured differently than its book value, which is the value of Arcturus that is recorded on the company's balance sheet. Investors also form their own opinion of Arcturus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Arcturus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcturus Therapeutics' market value can be influenced by many factors that don't directly affect Arcturus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Arcturus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcturus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcturus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.